HIF1A and Obesity: However, caution should be taken since chronic systemic HIF1α inactivation (genetic or pharmacological manipulation) attenuates WAT expansion and obesity (Sun et al., 2013; Soro-Arnaiz et al., 2016) despite of the HIF1a-dependent beneficial metabolic effects in the hypothalamus.